COMMUNIQUÉS West-GlobeNewswire

Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
07/05/2018
IND for KB103 to treat dystrophic epidermolysis bullosa (DEB) cleared by FDA Patient enrollment in Phase 1/2 study of KB103 to begin in May 2018 at Stanford University Krystal Biotech’s KB103 receives Orphan Medicinal [...]
RedHill Biopharma Announces Last Patient Assessed for Primary Endpoint in RHB-104 Phase III Study for Crohn’s Disease
07/05/2018
Top-line results from the Phase III study with RHB-104 for Crohn’s disease are expected to be announced in approximately three months Worldwide sales of Crohn’s disease therapies are estimated to exceed $10 billion in [...]
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
07/05/2018
Fourth Quarter Net Income Increased 36% Fourth Quarter EPS $0.50 per share vs $0.37 per share DELRAY BEACH, Fla., May 07, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) today announced its financial [...]
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma
07/05/2018
Duke Medical Center Opens for Patient Enrollment NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic [...]
Transactions under Novozymes’ stock buyback program
07/05/2018
Please read the full announcement in the attached PDF Attachment 2018_26_Stock_Buybackprogram_EN
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
07/05/2018
Design for single pivotal phase 3 trial validated by European Medicines Agency Regulatory pathway towards European market approval mapped out Strategy update scheduled together with earnings release for May 15, 2018 Zug [...]
Flexion Therapeutics Names David Arkowitz as Chief Financial Officer
07/05/2018
BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that David Arkowitz has been named Chief Financial Officer (CFO). Mr. Arkowitz brings more than 25 years of [...]
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2018 Financial Results on Thursday, May 10, 2018
07/05/2018
BOSTON, May 07, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
Share buy-back week 18/2018
07/05/2018
Announcement 7 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 May 2018
07/05/2018
Bagsværd, Denmark, 7 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]
Mike Weinstein to Join Medtronic as Senior Vice President of Strategy
07/05/2018
DUBLIN - May 7, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role, Weinstein will work with [...]
Projects of decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018.
07/05/2018
Latvia, 2018-05-07 11:52 CEST (GLOBE NEWSWIRE) -- Projects of decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018. Member of the Board: Juris Imaks, phone: 29512492
NOTICE ON CONVENING OF ORDINARY SHAREHOLDER’S MEETING.
07/05/2018
Latvia, 2018-05-07 09:52 CEST (GLOBE NEWSWIRE) -- The Management Board of Latvijas Jūras medicīnas centrs JSC hereby makes an announcement on convening of an ordinary general meeting of shareholders on June 12, 2018 at [...]
Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA
07/05/2018
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) is pleased to announce the establishment of new subsidiary Veritas [...]
Ambu A/S: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)
07/05/2018
Reporting organic growth in Q2 of 15%, Ambu is well on the way to realising its Big Five 2020 targets with satisfactory gross margins and earnings. The organic growth outlook in local currencies for the year is raised [...]
OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas
07/05/2018
OSE-127 significantly decreases inflammation in colon biopsies from patients with inflammatory bowel diseases and enhances regulatory T-lymphocytes, the cells that fight inflammation. In patients with active mucosal [...]
Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
07/05/2018
Alcon Cares to donate 100 reprocessed Infiniti ® units to clinics helping underserved patients in Asia, Central and South America, and Africa over the next three years Program to increase access to eye care and the [...]
Dentsply Sirona Reports First Quarter 2018 Results
07/05/2018
Reported Q1 revenues of $956.1 million, up 6.2% compared to prior year; constant currency growth 1 of negative 1.1% Q1 2018 GAAP EPS of $0.35 with Q1 2018 non-GAAP adjusted EPS of $0.45 Updated 2018 guidance: non-GAAP [...]
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
06/05/2018
The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system BrainsWay will be demonstrating the new [...]

Pages